LOC105378641: A Potential Drug Target for various Diseases (G105378641)
LOC105378641: A Potential Drug Target for various Diseases
LOC105378641 is a novel protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.
The protein LOC105378641 is a member of the LOC105 family, which is known for its role in regulating cellular processes such as cell adhesion, migration, and survival. LOC105378641 is a 21-kDa protein that consists of 129 amino acid residues. It has a unique structure, with a clear N-terminus, a hydrophobic middle region, and a C-terminus that is rich in acidic amino acids.
One of the key features of LOC105378641 is its ability to interact with various signaling pathways, including the NF-kappa pathway. NF-kappa is a well-known signaling pathway that is involved in various cellular processes, including cell growth, differentiation, and inflammation. LOC105378641 has been shown to play a role in regulating NF-kappa signaling by interacting with its extracellular domain, which consists of a single amino acid residue.
In addition to its role in NF-kappa signaling, LOC105378641 has also been shown to be involved in several other signaling pathways, including the PI3K/Akt signaling pathway, the NF-kappa-B signaling pathway, and the T-cell signaling pathway. These signaling pathways are important for the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The potential drug target status of LOC105378641 is based on several factors. Firstly, its unique structure and function make it an attractive target for researchers to study and develop new treatments. Secondly, its involvement in several important signaling pathways makes it a potential drug target for a wide range of diseases.
LOC105378641 has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that LOC105378641 is overexpressed in various cancer tissues and that it is involved in the development and progression of these diseases. Additionally, LOC105378641 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
Furthermore, LOC105378641 has also been shown to be involved in the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. In these disorders, the immune system attacks the body's own tissues, leading to inflammation and damage. LOC105378641 has been shown to play a role in the regulation of immune responses and has been shown to be involved in the development and progression of autoimmune disorders.
The potential clinical applications of LOC105378641 as a drug target or biomarker are vast. For example, LOC105378641 has been shown to be a potential therapeutic target for various cancers, including breast, ovarian, and colorectal cancers. Studies have shown that LOC105378641 can inhibit the growth and migration of cancer cells, and may be an effective anti-cancer drug.
LOC105378641 may also have potential applications as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that LOC105378641 can be used as a biomarker for cancer, by detecting its expression in cancer tissues
Protein Name: Uncharacterized LOC105378641
The "LOC105378641 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378641 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098
